Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Sands

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Nature|December 24, 1992
Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transferJ H Wolfe, M S Sands, J E Barker, et al.
The Journal of Biological Chemistry|September 20, 2001
Biodistribution, kinetics, and efficacy of highly phosphorylated and non-phosphorylated beta-glucuronidase in the murine model of mucopolysaccharidosis VIIM S Sands, C A Vogler, K K Ohlemiller, et al.
Human Gene Therapy|March 27, 2001
CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in miceL Xu, T Daly, C Gao, et al.
Gene Therapy|September 26, 2001
Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectorsA Donsante, C Vogler, N Muzyczka, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 29, 2001
Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VIIW A Frisella, L H O'Connor, C A Vogler, et al.
The Journal of Clinical Investigation|June 1, 1994
Enzyme replacement therapy for murine mucopolysaccharidosis type VIIM S Sands, C Vogler, J W Kyle, et al.
Pediatric Research|June 15, 1999
Enzyme replacement in murine mucopolysaccharidosis type VII: neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapyC Vogler, B Levy, N J Galvin, et al.
The Journal of Clinical Investigation|April 29, 1998
Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory functionL H O'Connor, L C Erway, C A Vogler, et al.
Gene Therapy|October 18, 2013
Adeno-associated virus serotypes 9 and rh10 mediate strong neuronal transduction of the dog brainG P Swain, M Prociuk, J H Bagel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2000
Gene transfer of low levels of beta-glucuronidase corrects hepatic lysosomal storage in a large animal model of mucopolysaccharidosis VIIJ H Wolfe, M S Sands, N Harel, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Nature|December 24, 1992
Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transferJ H Wolfe, M S Sands, J E Barker, et al.
The Journal of Biological Chemistry|September 20, 2001
Biodistribution, kinetics, and efficacy of highly phosphorylated and non-phosphorylated beta-glucuronidase in the murine model of mucopolysaccharidosis VIIM S Sands, C A Vogler, K K Ohlemiller, et al.
Human Gene Therapy|March 27, 2001
CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in miceL Xu, T Daly, C Gao, et al.
Gene Therapy|September 26, 2001
Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectorsA Donsante, C Vogler, N Muzyczka, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 29, 2001
Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VIIW A Frisella, L H O'Connor, C A Vogler, et al.
The Journal of Clinical Investigation|June 1, 1994
Enzyme replacement therapy for murine mucopolysaccharidosis type VIIM S Sands, C Vogler, J W Kyle, et al.
Pediatric Research|June 15, 1999
Enzyme replacement in murine mucopolysaccharidosis type VII: neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapyC Vogler, B Levy, N J Galvin, et al.
The Journal of Clinical Investigation|April 29, 1998
Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory functionL H O'Connor, L C Erway, C A Vogler, et al.
Gene Therapy|October 18, 2013
Adeno-associated virus serotypes 9 and rh10 mediate strong neuronal transduction of the dog brainG P Swain, M Prociuk, J H Bagel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2000
Gene transfer of low levels of beta-glucuronidase corrects hepatic lysosomal storage in a large animal model of mucopolysaccharidosis VIIJ H Wolfe, M S Sands, N Harel, et al.
Pageof 5